1. Signaling Pathways
  2. Epigenetics
    Metabolic Enzyme/Protease
  3. Methionine Adenosyltransferase (MAT)

Methionine Adenosyltransferase (MAT)

S-adenosylmethionine Synthetase

Methionine adenosyltransferases (MATs), also known as S-Adenosylmethionine synthetase, are essential enzymes for life as they catalyzes the synthesis of one of the most important and pivotal biological molecules, S-adenosyl-methionine. S-adenosyl-methionine is the biological methyl donor required for a plethora of reactions within the cell.Mammalian systems express two genes, MAT1A and MAT2A, which encode for MATα1 and MATα2, the catalytic subunits of the MAT isoenzymes, respectively. A third gene MAT2B, encodes a regulatory subunit known as MATβ which controls the activity of MATα2. MAT1A, which is mainly expressed in hepatocytes, maintains the differentiated state of these cells, whilst MAT2A and MAT2B are expressed in extrahepatic tissues as well as non-parenchymal cells of the liver (e.g., hepatic stellate and Kupffer cells).

Methionine Adenosyltransferase (MAT) Related Products (24):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-155148
    MAT2A-IN-11
    Inhibitor
    MAT2A Allosteric inhibitor 1 (compound 5) is a MAT2A selective inhibitor of methionine adenosyltransferase (MAT) with an IC50 of 6.8 nM.
    MAT2A-IN-11
  • HY-161298
    MAT2A-IN-15
    Inhibitor
    MAT2A-IN-15 (compound 8) is an inhibitor of MAT2A.
    MAT2A-IN-15
  • HY-149915
    MAT2A-IN-10
    Inhibitor
    MAT2A-IN-10 (Compound 28) is an orally active MAT2A inhibitor with an IC50 of 26 nM. MAT2A-IN-10 can be used for the research of cancer.
    MAT2A-IN-10
  • HY-144179
    MAT2A-IN-4
    Inhibitor
    MAT2A-IN-4 is a methionine adenosyltransferase 2A (MAT2A) inhibitor extracted from patent WO2020123395A1 compound 426 . MAT2A-IN-4 can be used for the research of cancer.
    MAT2A-IN-4